Dr. Douglas C Dycus, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3698 S Grundy Quarles Hwy, Gainesboro, TN 38562 Phone: 931-268-3224 Fax: 931-268-3228 |
News Archive
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare AG announced that VEGF Trap-Eye showed positive results in a Phase 2 study in patients with diabetic macular edema (DME).
Medicaid recipients will face co-pays for some treatments and have their medical services tracked as part of a program overhaul that is intended to lower the costs of providing health care, Gov. Susana Martinez's administration announced Monday. There will be no changes in determining who qualifies for Medicaid, which serves about a quarter of New Mexico's population (Massey, 7/15).
Affymetrix, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its CytoScan Dx Assay. This assay is intended for the postnatal detection of DNA copy number variants in patients referred for chromosomal testing. CytoScan Dx Assay is designed to help physicians diagnose children's developmental and intellectual disabilities more comprehensively by enabling a high-resolution genome-wide analysis of genetic aberrations. High resolution analysis can reveal small aberrations not readily seen using traditional techniques.
Researchers from Princeton University have identified genes important for age-related cognitive declines in memory in adult worm neurons, which had not been studied previously. The research, published in the journal Nature, could eventually point the way toward therapies to extend life and enhance health in aging human populations.
St. Michael's Hospital today became the first in North America to use a novel blood-cleaning procedure for a kidney patient that will allow him to receive a transplant from a donor with a different blood type.
› Verified 3 days ago